Research library · Genomics
A genetic variant of uncertain significance needs a follow-up plan
Draft • Research checked 4 October 2026 • AI-assisted DomDNA editorial content. No independent clinical review or publication is claimed. General education, not individual medical advice.
A genetic report can name a gene, give a precise-looking code and still leave an important question unanswered. The phrase “variant of uncertain significance”, often shortened to VUS, describes that uncertainty. Finding the letters on a report is a reason to ask for an explanation, rather than to turn the result into a diagnosis yourself.
It can feel frustrating to receive something so technical without a simple answer. You are allowed to ask what the result means for the question that led to testing, what it does not establish, and whether any follow-up is planned. Those questions are more useful than trying to infer certainty from the length of the report.
Uncertain has a specific meaning
The National Human Genome Research Institute glossary explains that a VUS is a genetic change whose connection to disease is not clear. The laboratory has identified a variant; its clinical significance remains uncertain. That classification is different from a finding established as disease-causing.
Keep the exact wording when discussing it. “A variant was found” can sound very different from “a variant of uncertain significance was reported”. Dropping the second half changes the meaning. Equally, replacing it with “nothing was found” erases information that may be relevant to future interpretation.
If you found the result through an automated interpretation service, say so. Bring the source report and explain how the additional interpretation was produced. A clinician needs to know which laboratory or service made the classification and what the original test was intended to investigate.
The clinical question still matters
MedlinePlus guidance on interpreting genetic results describes why an uninformative result may fail to confirm or rule out a diagnosis. Interpretation includes the reason for testing and other clinical information. An uncertain result should not erase symptoms or family history that still need attention.
Ask the person who ordered the test to connect the report back to your original question. Did it provide an answer? If not, what remains unresolved? You can write those as separate lines in your notes. This prevents “the test is finished” from quietly becoming “the clinical question is settled”.
There is no need to become a variant-classification expert before that conversation. Save the gene name and variant identifier accurately, but do not assume that matching a code in an online database establishes what it means for you. Public entries may concern different evidence, conditions or classification dates.
Discuss decisions with the right team
The National Cancer Institute's genetic-testing fact sheet explains that a VUS is usually not used to make healthcare decisions in hereditary-cancer testing. It also discusses possible reclassification and staying in contact with the testing provider. That guidance comes from a cancer-testing context; it is not a personal management plan for every genetic condition.
Do not start treatment, change screening or arrange relatives' tests solely because you have interpreted a VUS yourself. Ask the relevant genetics or clinical team whether any action is appropriate and what evidence supports it. They can also explain whether information from relatives would help and how that should be collected.
The practical follow-up is often administrative as well as scientific. Ask who holds the report, whether updated interpretations are communicated, and how to keep your contact details current. Do not assume every service automatically rechecks every result forever. If no update policy is clear, record that as a question to resolve.
Keep a readable record
Store the report date, laboratory name and exact classification together. Add a separate note summarising the explanation you received and when you received it. Preserve the original if a later report changes the classification, so the sequence remains understandable.
Uncertainty is difficult enough without an extra layer of copied fragments and missing dates. A clear record supports the next clinical conversation without pretending to answer it. For broader lifestyle education based on your answers, explore DomDNA's free educational health quiz. It does not classify genetic variants, analyse DNA or recommend clinical screening.
Original source and access ledger
- NHGRI VUS definition
sourceDate: Date not established; accessed 2026-10-04
type: Government genetics glossary
population: People reading genetic variant classifications
endpoint: Meaning of classification
supportedClaimAndLimit: A variant's disease connection remains unclear; precision of its identifier does not establish pathogenicity.
fundingAndConflicts: NIH institute education; no commercial classification service endorsement.
accessEvidence: Official source text opened and read via web on 2026-10-04; no personal health data transmitted.
researchDate: 2026-10-04
correctionStatus: Access-date source check only; no comprehensive correction, retraction or guideline-surveillance audit claimed.
- MedlinePlus result interpretation
sourceDate: Date not established; accessed 2026-10-04
type: Government genetics education
population: People receiving genetic test results
endpoint: Interpretation and uninformative results
supportedClaimAndLimit: An uninformative result may not confirm or exclude diagnosis; purpose and clinical context remain relevant.
fundingAndConflicts: US National Library of Medicine education; no personal report interpretation.
accessEvidence: Official source text opened and read via web on 2026-10-04; no personal health data transmitted.
researchDate: 2026-10-04
correctionStatus: Access-date source check only; no comprehensive correction, retraction or guideline-surveillance audit claimed.
- NCI inherited-cancer testing
sourceDate: Date not established; accessed 2026-10-04
type: Government cancer genetics fact sheet
population: Hereditary-cancer testing, not all genetic conditions
endpoint: Clinical use and possible reclassification of VUS
supportedClaimAndLimit: VUS usually does not guide healthcare decisions in this context; contact testing provider about updates. No promise of automatic reanalysis.
fundingAndConflicts: National Cancer Institute; cancer-specific education rather than a trial.
accessEvidence: Official source text opened and read via web on 2026-10-04; no personal health data transmitted.
researchDate: 2026-10-04
correctionStatus: Access-date source check only; no comprehensive correction, retraction or guideline-surveillance audit claimed.
Download exact original article Markdown · Download exact source and unsent social pack
Finished companion media
Silent films, slides and source captions on the separate dashboard. Original preview and historical product limits remain in their captions. No social campaign has been sent.